. Author manuscript; available in PMC: 2009 Mar 20.

Published in final edited form as: J Neurooncol. 2008 Jan 30;88(1):43–50. doi: 10.1007/s11060-008-9530-8

Table 2.

Treatment characteristics.

Characteristic	Group 1 Adjuvant TMZ only N=21	Group 2 Concurrent & adjuvant TMZ N=22	P value
Resection status
Biopsy	6 (29%)	5 (23%)
STR	8 (38%)	12 (54%)	0.5812¹
GTR	7 (33%)	5 (23%)

XRT dose
56-58 Gy	2 (10%)	1 (5%)	0.9201¹
≥59.4 Gy	19 (90%)	21 (95%)

Cycles of TMZ	6 [3,8]	9.5 [4,16]	0.2224²

(median, IQ range)

Salvage local tx
SRS	2 (10%)	1 (5%)
SRT	1 (5%)	3 (14%)	0.1473¹
Brachytherapy	1 (5%)	1 (5%)
Salvage surgery	3 (14%)	3 (14%)

P value derived from Fisher's exact test.

P value derived from Wilcoxon rank sum test.